(19)

(11)

EP 4 770 661 A2

(12)

(88) Date of publication A3: 17.04.2025 (43) Date of publication: 08.07.2026 Bulletin 2026/28 (21) Application number: 24861224.4 (22) Date of filing: 30.08.2024

(51) International Patent Classification (IPC):  A61K 38/19(2006.01) A61K 38/16(2006.01) (52) Cooperative Patent Classification (CPC): A61P 35/00; A61K 45/06; A61K 31/675; A61K 31/395; A61K 38/193; A61K 38/08; A61K 38/12   C-Sets: A61K 38/12, A61K 2300/00; A61K 31/675, A61K 2300/00; A61K 31/395, A61K 2300/00; A61K 38/193, A61K 2300/00; A61K 38/08, A61K 2300/00; (86) International application number: PCT/US2024/044862 (87) International publication number: WO 2025/050038 (06.03.2025 Gazette 2025/10)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 30.08.2023 US 202363579773 P (71) Applicants: GPCR Therapeutics, Inc. Seoul 08790, (KR) Cardarelli, Josephine San Carlos, California 94070 (US)	(72) Inventors: SUKHTANKAR, Devki Fremont, California 94555 (US) CAYTON, Thomas Pleasanton, California 94566 (US) CARDARELLI, Josephine San Carlos, California 94070 (US) (74) Representative: Berggren Oy  P.O. Box 16 Fabianinkatu 21 00101 Helsinki 00101 Helsinki (FI)